Company Filing History:
Years Active: 2011
Title: Innovations of Kai Lindenstruth
Introduction
Kai Lindenstruth is a notable inventor based in Loerrach, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that address various cognitive disorders. His work is characterized by a focus on innovative solutions for complex medical challenges.
Latest Patents
Lindenstruth holds a patent for a compound titled "Solid forms of [4-(3-fluoro-5-trifluoromethyl-pyridin-2-yl)-piperazin-1-yl-[5-methanesulfonyl-2-((S)-2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-methanone." This invention relates to four distinct crystalline forms and an amorphous form of the compound. The patent outlines their use in preparing pharmaceutical compositions suitable for treating psychoses, pain, neurodegenerative dysfunction in memory and learning, schizophrenia, dementia, and other cognitive impairments, including attention deficit disorders and Alzheimer's disease.
Career Highlights
Throughout his career, Lindenstruth has worked with prominent companies in the pharmaceutical industry, including Hoffmann-La Roche Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.
Collaborations
Lindenstruth has collaborated with several professionals in his field, including Andre Bubendorf and Annette Deynet-Vucenovic. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Kai Lindenstruth's contributions to the pharmaceutical industry exemplify the impact of innovative thinking in addressing complex health issues. His patent work and collaborations highlight the importance of research and development in creating effective treatments for cognitive disorders.